OpenAlex
PricingAboutJobs
Log inGet started
Work

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors-Related Hematological Toxicities in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

HTML

Year: 2019
Type: conference-abstract
Source: Blood
DOI: 10.1182/blood-2019-123531
Authors: Bradley J. Grant, Anita Sultan, Nicholas D'Cunha, Chandler Graf, Sriman Swarup, Myint Aung Win, Ei Moe Phyu, Thura Win Htut, Myat Min Han, Yin Mon Myat, Nimesh Adhikari, Nyein Htway Yu, Donald P. Quick, Kyaw Zin Thein
Institutions: Texas Tech University Health Sciences Center, Texas Tech University, Lewis Gale Medical Center, Aberdeen Royal Infirmary, The University of Texas MD Anderson Cancer Center, University College Dublin, Kingsbrook Jewish Medical Center
Language: English

Topic: Chronic Lymphocytic Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: PI3K inhibitors, idelalisib, duvelisib, chronic lymphocytic leukemia, small lymphocytic lymphoma, relapsed/refractory disease, hematologic toxicity, anemia, neutropenia, thrombocytopenia, B cell receptor signaling, adverse events, ofatumumab, rituximab
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2987967973
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security